The Asian Society of Endometriosis and Adenomyosis guidelines for managing adenomyosis
- PMID: 37701076
- PMCID: PMC10493363
- DOI: 10.1002/rmb2.12535
The Asian Society of Endometriosis and Adenomyosis guidelines for managing adenomyosis
Abstract
This is the first guidelines for adenomyosis from the Asian Society of Endometriosis and Adenomyosis.
© 2023 The Authors. Reproductive Medicine and Biology published by John Wiley & Sons Australia, Ltd on behalf of Japan Society for Reproductive Medicine.
Conflict of interest statement
Tasuku Harada is an Editorial Board member of Reproductive Medicine and Biology and a 1st author of this article. To minimize bias, he was excluded from all editorial decision‐making related to the acceptance of this article for publication. Other coauthors declare no conflicts of interest for this article.
Similar articles
-
Development of a core outcome set and outcome definitions for studies on uterus-sparing treatments of adenomyosis (COSAR): an international multistakeholder-modified Delphi consensus study.Hum Reprod. 2022 Aug 25;37(9):2012-2031. doi: 10.1093/humrep/deac166. Hum Reprod. 2022. PMID: 35906919 Free PMC article.
-
COMT 158G/A and CYP1B1 432C/G polymorphisms increase the risk of endometriosis and adenomyosis: a meta-analysis.Eur J Obstet Gynecol Reprod Biol. 2014 Aug;179:17-21. doi: 10.1016/j.ejogrb.2014.04.039. Epub 2014 May 13. Eur J Obstet Gynecol Reprod Biol. 2014. PMID: 24965973
-
Ultrasound diagnosis of endometriosis and adenomyosis: State of the art.Best Pract Res Clin Obstet Gynaecol. 2018 Aug;51:16-24. doi: 10.1016/j.bpobgyn.2018.01.013. Epub 2018 Feb 14. Best Pract Res Clin Obstet Gynaecol. 2018. PMID: 29506961 Review.
-
Migraine Is More Prevalent in Advanced-Stage Endometriosis, Especially When Co-Occuring with Adenomoysis.Front Endocrinol (Lausanne). 2022 Jan 24;12:814474. doi: 10.3389/fendo.2021.814474. eCollection 2021. Front Endocrinol (Lausanne). 2022. PMID: 35140688 Free PMC article.
-
Reproductive, obstetric, and perinatal outcomes of women with adenomyosis and endometriosis: a systematic review and meta-analysis.Hum Reprod Update. 2019 Sep 11;25(5):592-632. doi: 10.1093/humupd/dmz012. Hum Reprod Update. 2019. PMID: 31318420
Cited by
-
Adenomyosis-A Call for Awareness, Early Detection, and Effective Treatment Strategies: A Narrative Review.Healthcare (Basel). 2024 Aug 17;12(16):1641. doi: 10.3390/healthcare12161641. Healthcare (Basel). 2024. PMID: 39201199 Free PMC article. Review.
-
Risk factors and countermeasures for abnormal uterine bleeding during dienogest therapy for adenomyosis: a review.Front Reprod Health. 2025 Jun 30;7:1550814. doi: 10.3389/frph.2025.1550814. eCollection 2025. Front Reprod Health. 2025. PMID: 40662092 Free PMC article. Review.
-
Prognostic factors of progesterone resistance in symptomatic adenomyosis: impact of lesion localization on treatment outcome of levonorgestrel intrauterine system.BMC Womens Health. 2025 Jun 13;25(1):286. doi: 10.1186/s12905-025-03817-w. BMC Womens Health. 2025. PMID: 40514651 Free PMC article.
-
Medical treatment before in-vitro fertilization in patients with adenomyosis: a systematic review and meta-analysis.J Assist Reprod Genet. 2025 Feb;42(2):381-388. doi: 10.1007/s10815-024-03323-2. Epub 2024 Dec 12. J Assist Reprod Genet. 2025. PMID: 39666211
-
Uterine anteroposterior diameter predicts spontaneous pregnancy outcomes in women under 35 years with adenomyosis: a retrospective study.BMC Pregnancy Childbirth. 2025 Jul 4;25(1):727. doi: 10.1186/s12884-025-07828-1. BMC Pregnancy Childbirth. 2025. PMID: 40615802 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Medical